FDA Okays AI-Based Prostate Cancer Risk-Stratification Tool
The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artific [...]
Identifying Patients Who Will Benefit From Intensified Prostate Cancer Treatment
Identifying men with high-risk, non-metastatic prostate cancer who will truly benefit from intensified treatment from therape [...]
AI Tool Accurately Predicts Prostate Cancer Outcomes Across Racial Groups
Mack Roach III, MD, professor of radiation oncology, medical oncology, and urology at the University of California, San Franc [...]
Multimodal AI Shows No Evidence of Bias in Prostate Cancer Study
The study evaluated the performance of a multimodal artificial intelligence model to close gaps in care and validate that AI [...]
Artera Bullish on Prostate Cancer Test Following NYS Approval, Impending Registry Study
NEW YORK – Startup firm Artera is continuing to make commercial progress with its artificial intelligence-based prostate canc [...]
How AI Is Helping Cancer Patients: Saving Lives And Money
Cancer treatment is costly. The average cost of cancer care in the U.S. is around $150,000 per patient—more than four times t [...]
TIME100 Health: Andre Esteva
Andre Esteva is pioneering a future where AI can personalize therapies to improve health. “Doctors are the first to tell you [...]
Precision Medicine for Prostate Cancer — AI can help patients decide whether active surveillance is right for them
The multimodal ArteraAI Prostate Testopens in a new tab or window (AI Test) is currently the only test that provides insights [...]
The 4 step process to achieve AI data locality while serving AI globally
As part of Artera’s mission to improve patient outcomes globally, Artera launched a highly successful product for patients wi [...]